/ Source: The Associated Press
Drug developer Pfizer Inc. said Tuesday it signed a deal with Bausch & Lomb- to co-promote prescription eye-care drugs in the U.S.
Terms of the five-year deal were not disclosed. The partnership includes Pfizer's eye-care solution Xalatan and Bausch & Lomb's Alrex, among other products. Meanwhile, Pfizer said it will continue to maintain three developing eye-care products separate from the partnership.
The eye-care announcement follows New York-based Pfizer's move to begin selling dozens more generic drugs in the U.S. and Europe through new deals with Indian generic company Aurobindo Pharma Ltd.
Pfizer shares rose 17 cents to $11.83 in premarket trading.
